Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2006-08-29
2006-08-29
Canella, Karen A. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C424S277100
Reexamination Certificate
active
07098311
ABSTRACT:
The invention provides isolated nucleic acids molecules, designated jAZF1, jjAZ1 or jAZF1/jjAZ1 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing jAZF1, jjAZ1 or jAZF1/jjAZ1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a jAZF1, jjAZ1 or jAZF1/jjAZ1 gene has been introduced or disrupted. The invention still further provides isolated jAZF1, jjAZ1 or jAZF1/jjAZ1 proteins, fusion proteins, antigenic peptides and anti-jAZF1, jjAZ1 or jAZF1/jjAZ1 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
REFERENCES:
patent: WO 01/55322 (2001-08-01), None
Abstract of Ambros (Materia Medica Polona, 1992, vol. 24, pp. 76-78).
Abstract of Chan et al (Molecular and Cellular Probes, 1987, vol. 1, pp. 73-82).
Abstract of Sonobe et al (Cancer Genet Cytogenet, Jul. 1999, vol. 112, pp. 34-37).
Abstract of Chu et al (American Journal of Clinical Pathology, Mar. 2000, vol. 113, pp. 374-382).
Abstract of Nagase et al (DNA Research, 1995, vol. 2, pp. 167-174).
Accession No. Q15022, Mar. 2003.
Accession No. AAU15978, Nov. 2001.
Nagase et al (DNA Research, 1995, vol. 2, pp. 167-174).
Berg, J.M., et al., (1996) Science 271, 1081-1085.
Clarke, N.D. et al., (1998) sCIENCE 282, 2018-2022.
Dal Cin, P., et al., (1992) Cancer Genet. Cytogenet. 53, 43-46.
Hennig, Y., et al., (1997) Cancer Genet. Cytogenet. 98, 84-86.
Koontz, J., et al., (2001) Proceedings of the National Academy of Sciences, vol. 98, No. 11, 6348-6353.
Nasmyth, K., et al., (2000) Science 288, 1379-1384.
Pauwels, P., et al., (1996) Histopathology 29, 84-87.
Sreekantaiah, C., et al., (1991) Cancer Genet. Cytogenet. 55, 163-166.
Xu, Z., et al., (1998) Genetics 150, 1419-1428.
Yamamoto, A., et al., (1996) J. Cell Biol. 133, 85-97.
Yamamoto, A., et al., (1996) J. Cell Biol. 133, 99-110.
Database GenBank, Accession No. AI595264, Marra, M. et al. 1999; the eDNA molecule comprises a polynucleotide sequence that is 70.7%identical over its entire length to SEQ ID No. 3 and also comprises a polynucleotide sequence of SEQ ID No. 1.
Database GenBank, Accession No. AK000711, Direct Submission, Sugano, S., et al. Feb. 15, 2000; the eDNA molecule comprises a polynucleotide sequence that is 100% identical to a polynucleotide sequence of SEQ ID No. 3.
Koontz Jason
Sklar Jeffrey
Brigham and Women's Hospital
Canella Karen A.
Fish & Richardson P.C.
LandOfFree
Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3665971